These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


62 related items for PubMed ID: 2128970

  • 21. Elimination of hydrocortisone from the medium enables tissue plasminogen activator gene expression by normal and immortalized nonmalignant human epithelial cells.
    Myöhänen H, Virtanen I, Vaheri A.
    Biol Chem; 2001 Nov; 382(11):1563-73. PubMed ID: 11767946
    [Abstract] [Full Text] [Related]

  • 22. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines.
    Festoff BW, Rao JS, Maben C, Hantaï D.
    J Cell Physiol; 1990 Aug; 144(2):262-71. PubMed ID: 2199466
    [Abstract] [Full Text] [Related]

  • 23. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P, Ehnebom J, Inghardt T, Hansson L, Lindberg M, Linschoten M, Strömqvist M, Deinum J.
    Biochemistry; 1998 Feb 03; 37(5):1227-34. PubMed ID: 9477948
    [Abstract] [Full Text] [Related]

  • 24. A monoclonal antibody that does not recognize tissue-type plasminogen activator bound to its naturally occurring inhibitor.
    Schleef RR, Wagner NV, Sinha M, Loskutoff DJ.
    Thromb Haemost; 1986 Dec 15; 56(3):328-32. PubMed ID: 2436333
    [Abstract] [Full Text] [Related]

  • 25. Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on the growth inhibitory and increased phosphatidylinositol (PI) responses induced by epidermal growth factor (EGF) in A431 cells.
    Smith KB, Losonczy I, Sahai A, Pannerselvam M, Fehnel P, Salomon DS.
    J Cell Physiol; 1983 Oct 15; 117(1):91-100. PubMed ID: 6311852
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
    Park KW, Choi SH, Song XX, Funahashi H, Niwa K.
    Biol Reprod; 1999 Jul 15; 61(1):298-304. PubMed ID: 10377062
    [Abstract] [Full Text] [Related]

  • 32. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor.
    Mawatari M, Okamura K, Matsuda T, Hamanaka R, Mizoguchi H, Higashio K, Kohno K, Kuwano M.
    Exp Cell Res; 1991 Feb 15; 192(2):574-80. PubMed ID: 1899074
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.
    Hopkins WE, Westerhausen DR, Sobel BE, Billadello JJ.
    Nucleic Acids Res; 1991 Jan 11; 19(1):163-8. PubMed ID: 2011496
    [Abstract] [Full Text] [Related]

  • 35. Synthesis of urokinase-type plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: stimulation by phorbol ester.
    Presta M, Ennas MG, Torelli S, Ragnotti G, Gremo F.
    J Neurochem; 1990 Nov 11; 55(5):1647-54. PubMed ID: 2213017
    [Abstract] [Full Text] [Related]

  • 36. Absence of specific cell-surface binding of tissue plasminogen activator in uterine cells.
    Ayub M, Jenkins N, White JO.
    J Mol Endocrinol; 1990 Aug 11; 5(1):7-14. PubMed ID: 2168711
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Modulation of plasminogen activators and plasminogen activator inhibitors by TGF-beta, IL-1 alpha and EGF in fetal rat calvaria cells at different times of culture.
    Laschinger CA, Bellows CG, Wasi S.
    Bone Miner; 1991 Apr 11; 13(1):23-34. PubMed ID: 2065216
    [Abstract] [Full Text] [Related]

  • 40. The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator.
    Kaneko M, Mimuro J, Matsuda M, Sakata Y.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):1160-6. PubMed ID: 1908232
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.